The closed system transfer devices (CSTDs) market is projected to reach USD 2.09 billion by 2030, from USD 1.49 billion in 2025, at a CAGR of 7.0%.
Scope of the Report
Years Considered for the Study
2024-2030
Base Year
2024
Forecast Period
2024-2030
Units Considered
Value (USD billion)
Segments
Component, Closing Mechanism, Type, Technology, End User, and Region
Regions covered
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
With the increased consciousness and interest in the safety of healthcare workers, there is an increasing market demand for closed system transfer devices. Healthcare institutions are spending more on these devices to advance safety procedures and shield their workers against the dangers of working with unsafe drugs. This rising demand will, therefore, boost the growth of the closed system transfer devices market as healthcare facilities prioritize taking safety measures to secure their workforce.
Depending on the closing mechanism, the color-to-color alignment system segmented shall increase at the highest CAGR in the closed system transfer devices market.
On the basis of components, the vial access segment held the largest market share of the closed system transfer devices market. Vial access components have a crucial function in reducing the risk of needlestick injury among healthcare professionals and avoiding drug contamination while transferring. Additionally, ease of handling enables quick medication preparation and minimizes the risk of errors related to open systems. Thus, addressing safety and efficiency requirements, the vial access components segment is likely to drive the market.
Based on the end-user segment, the hospitals & clinics subsegment is dominated the closed system transfer devices market. In contrast to other medical facilities, hospitals and clinics have a bigger budget for medical equipment. This gives them the capability to spend on the newest CSTD technology while keeping abreast with regulations and best practices. Further, hospitals and clinics are under more rigid regulations on handling medication and employee protection. CSTDs assist them in fulfilling these needs by reducing the risk of exposure to dangerous drugs and avoiding medication errors.
North America is expected to account for the largest share of the closed system transfer devices market during the forecast period. This is due to the increased awareness by healthcare professionals towards the significance of the safe handling of drugs as well as a well-established infrastructure of healthcare and rigorous regulatory requirements. The region has been leading in the adoption of sophisticated medical technology to improve patient care and safety.
A breakdown of the primary participants (supply-side) for the closed system transfer devices market referred to for this report is provided below:
By Company Type: Tier 1: 42%, Tier 2: 37%, and Tier 3: 21%
By Designation: C-level: 39%, Director Level: 33%, and Others: 28%
By Region: North America: 64%, Europe: 17%, Asia Pacific: 7%, Latin America: 6%, Middle East & Africa: 6%
Prominent players in the closed system transfer device market are BD (US), ICU Medical, Inc. (US), EQUASHIELD (US), JMS Co. Ltd. (Japan), Baxter (US), B Braun Melsungen AG (Germany), West Pharmaceuticals Services, Inc. (US) and Terumo Corporation (Japan).
Research Coverage
The report evaluates the closed system transfer devices market and estimates the market size and future growth potential based on various segments, including closing mechanism, type, component, technology, end user, and region. The report also includes a competitive analysis of the major players in this market, along with company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will assist the market leaders/new entrants with data on the nearest approximations of the revenue numbers for the overall closed system transfer devices market and the subsegments. The report will assist stakeholders in understanding the competitive landscape and gain further insights to better place their businesses and make appropriate go-to-market strategies. The report assists the stakeholders in understanding the market pulse and gives them data on influential drivers, hindrances, obstacles, and opportunities in the market.
This report provides insights into the following points:
Analysis of key drivers (growing incidence of cancer and subsequent use of chemotherapy, Increasing regulatory approvals for oncology therapeutics, rising awareness about risks associated with handling antineoplastic drugs, stringent regulatory guidelines for handling hazardous medication), restraints (high implementation costs and limited reimbursements, Inconsistent regulatory compliance), opportunities (growth potential across therapeutic applications, rising healthcare expenditure in emerging economies) and challenges (impact of closed system transfer devices on drug quality, low awareness and poor implementation of protective measures)
Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global closed system transfer devices market
Market Development: Thorough knowledge and analysis of the profitable rising markets by closing mechanism, type, component, technology, end user, and region
Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global closed system transfer devices market
Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global closed system transfer devices market
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED AND REGIONAL SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 SCOPE-RELATED LIMITATIONS
2.6.2 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 CLOSED SYSTEM TRANSFER DEVICES MARKET OVERVIEW
4.2 ASIA PACIFIC: CLOSED SYSTEM TRANSFER DEVICES MARKET, BY TECHNOLOGY AND COUNTRY, 2024
4.3 CLOSED SYSTEM TRANSFER DEVICES MARKET: REGIONAL MIX
4.4 CLOSED SYSTEM TRANSFER DEVICES MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS
4.5 CLOSED SYSTEM TRANSFER DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing incidence of cancer and subsequent use of chemotherapy
5.2.1.2 Increasing regulatory approvals for oncology therapeutics
5.2.1.3 Rising awareness about risks associated with handling antineoplastic drugs
5.2.1.4 Stringent regulatory guidelines for handling hazardous medication
5.2.2 RESTRAINTS
5.2.2.1 High implementation costs and limited reimbursements
5.2.2.2 Inconsistent regulatory compliance
5.2.3 OPPORTUNITIES
5.2.3.1 Growth potential across therapeutic applications
5.2.3.2 Rising healthcare expenditure in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Impact of closed system transfer devices on drug quality
5.2.4.2 Low awareness and poor implementation of protective measures